TellWell
← Back to feed
Health4h ago82% confidenceConfidence 82% — the share of independent, credible sources corroborating the core facts.

US Measles Cases Exceed 2,000 as Outbreak Approaches Worst in Decades

1 source

The United States has recorded over 2,000 confirmed measles cases in 2025, approaching the worst year for the disease in decades, with experts estimating the true number is roughly three times higher. The outbreak is concentrated in unvaccinated and under-vaccinated communities, exacerbated by decades of vaccine misinformation and reduced federal public health funding. The situation is significant because measles is highly preventable through vaccination, and the outbreak threatens vulnerable populations including infants too young to be vaccinated.

The US has documented more than 2,030 confirmed measles cases as of early June 2025, tracking toward the worst year for measles in decades. Experts estimate the actual number of cases is approximately three times higher than confirmed reports. The outbreak is spreading primarily in unvaccinated and under-vaccinated communities, including among infants too young to receive vaccination. Public health experts attribute the crisis to multiple factors: decades of declining vaccination rates in some regions, widespread vaccine misinformation, and reduced federal funding for public health departments. The response has been complicated by political factors, with some state leadership deprioritizing outbreak communication. South Carolina's more coordinated public health response, which included regular updates from state leadership, resulted in containment and a 162% increase in vaccinations in one county, contrasting with less coordinated efforts in other states.

What's missing

The article does not specify the current measles vaccination rate nationally or in affected states, making it difficult to assess the precise proportion of the population at risk. Additionally, while the article mentions Robert F. Kennedy Jr.'s promotion of vitamin A as an unproven treatment, it does not detail the actual efficacy or safety profile of vitamin A supplementation in measles cases, nor does it provide context on what evidence-based treatments are recommended.

What different sources said

  • US measles cases pass 2,000 as outbreak nears worst in decades

Related

HealthConfidence 88% — the share of independent, credible sources corroborating the core facts.

Sydney Psychiatrist Retains Medical License After Sexual Assault Conviction

Gopi Ilawala, a Sydney psychiatrist convicted of sexually assaulting an intoxicated colleague in 2022, has been allowed to continue practicing medicine despite the state health regulator seeking to have his registration cancelled. The New South Wales Civil and Administrative Tribunal reprimanded him and imposed conditions rather than striking him off, citing his remorse, lack of prior convictions, and support from two senior psychiatrists. The decision raises questions about professional accountability and public protection in medical regulation.

1 source7m ago
HealthConfidence 82% — the share of independent, credible sources corroborating the core facts.

Australia's TGA to crack down on illegal peptides; government allocates $100m for arthritis research

Australia's Therapeutic Goods Administration has announced a crackdown on illegal peptides due to a surge in imports and online advertising, designating them a priority focus area. The federal government has simultaneously committed $100 million to medical research into arthritis prevention, diagnosis, and treatment. These developments reflect growing regulatory concerns about unregulated drugs and increased investment in chronic disease research.

1 source37m ago
HealthConfidence 58% — the share of independent, credible sources corroborating the core facts.

GLP-1 Drugs Like Ozempic May Help ADHD Symptoms, According to Patient Reports and Clinical Observations

Social media users and some patients are reporting that GLP-1 receptor agonist drugs like Ozempic appear to improve ADHD symptoms, including increased focus, reduced procrastination, and better impulse control. GLP-1s were originally developed to treat Type 2 diabetes but are being studied for various other conditions. While anecdotal reports are growing, no formal clinical trials are currently testing these drugs specifically for ADHD, and the mechanism behind any potential benefit remains unclear.

1 source37m ago